Authors' response: Cost-effectiveness evidence for HPV self-sampling could be improved by giving greater attention to vulnerable populations

Prev Med. 2020 Oct:139:106081. doi: 10.1016/j.ypmed.2020.106081. Epub 2020 Apr 4.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Female
  • Humans
  • Papillomaviridae*
  • Papillomavirus Infections*
  • Specimen Handling
  • Uterine Cervical Neoplasms*
  • Vulnerable Populations